** Medical device company's shares AVGR.O rise 9.8% to
$3.24 premarket
** Co announces launch of its Ocelot system, used in
treating obstructed coronary arteries, in Australia urn:newsml:reuters.com:*:nACSzccRca
** The image-guided platform offers a minimally invasive
therapy to heart patients who might need surgery
** Co says it has completed registration process for Ocelot
and the device is included on the Australian Register of
Therapeutic Goods, which permits distribution in the country
** Up to Friday's close, stock had fallen ~83% over the past
year
(Reporting by Tamara Mathias in Bengaluru)
((Tamara.Mathias@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 1208; Reuters Messaging:
tamara.mathias.thomsonreuters.com@reuters.net))